Gene · 4320
Papers3,235
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,235
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cerebrospinal fluid proteomics in recent-onset Narcolepsy type 1 reveals activation of the complement system. | Front Immunol | 2023 | 37122721 | PubTator, text mining | PubMed |
| Evaluation of Matrix Metalloproteases by Artificial Intelligence Techniques in Negative Biopsies as New Diagnostic Strategy in Prostate Cancer. | Int J Mol Sci | 2023 | 37108185 | PubTator, text mining | PubMed |
| Therapeutic Potential of Tumor Metabolic Reprogramming in Triple-Negative Breast Cancer. | Int J Mol Sci | 2023 | 37108109 | PubTator, text mining | PubMed |
| Proteomics-Based Identification of Dysregulated Proteins and Biomarker Discovery in Invasive Ductal Carcinoma, the Most Common Breast Cancer Subtype. | Proteomes | 2023 | 37092454 | PubTator, text mining | PubMed |
| The Extracellular Matrix: Its Composition, Function, Remodeling, and Role in Tumorigenesis. | Biomimetics (Basel) | 2023 | 37092398 | PubTator, text mining | PubMed |
| Machine learning-based integration develops an immune-related risk model for predicting prognosis of high-grade serous ovarian cancer and providing therapeutic strategies. | Front Immunol | 2023 | 37090728 | PubTator, text mining | PubMed |
S-1-propenyl-L-cysteine suppresses lipopolysaccharide-induced expression of matrix metalloproteinase-1 through inhibition of tumor necrosis factor-α converting enzyme-epidermal growth factor receptor axis in human gingival fibroblasts. | PLoS One | 2023 | 37083725 | PubTator, text mining | PubMed |
| Assessing Breast Cancer Molecular Subtypes Using Extracellular Vesicles' mRNA. | Anal Chem | 2023 | 37071799 | PubTator, text mining | PubMed |
| CircRNA: A new class of targets for gastric cancer drug resistance therapy. | Pathol Oncol Res | 2023 | 37065861 | PubTator, text mining | PubMed |
| Clustering and machine learning-based integration identify cancer associated fibroblasts genes' signature in head and neck squamous cell carcinoma. | Front Genet | 2023 | 37065499 | PubTator, text mining | PubMed |
| TMBIM6-mediated miR-181a expression regulates breast cancer cell migration and invasion via the MAPK/ERK signaling pathway. | J Cancer | 2023 | 37057283 | PubTator, text mining | PubMed |
| Progress in 7SK ribonucleoprotein structural biology. | Front Mol Biosci | 2023 | 37051324 | PubTator, text mining | PubMed |
| Fibroblasts as Turned Agents in Cancer Progression. | Cancers (Basel) | 2023 | 37046676 | PubTator, text mining | PubMed |
| Molecular landscape and emerging therapeutic strategies in breast cancer brain metastasis. | Ther Adv Med Oncol | 2023 | 37034479 | PubTator, text mining | PubMed |
| Pancreatic cancer and fibrosis: Targeting metabolic reprogramming and crosstalk of cancer-associated fibroblasts in the tumor microenvironment. | Front Immunol | 2023 | 37033960 | PubTator, text mining | PubMed |
| Integrative single-cell sequencing analysis distinguishes survival-associated cells from the breast cancer microenvironment. | Cancer Med | 2023 | 37021816 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| BCR-Net: A deep learning framework to predict breast cancer recurrence from histopathology images. | PLoS One | 2023 | 37014891 | PubTator, text mining | PubMed |
| Platform combining statistical modeling and patient-derived organoids to facilitate personalized treatment of colorectal carcinoma. | J Exp Clin Cancer Res | 2023 | 37013646 | PubTator, text mining | PubMed |
| The role of Th-17 cells and IL-17 in the metastatic spread of breast cancer: As a means of prognosis and therapeutic target. | Front Immunol | 2023 | 36993955 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4320/papers?page=18